Altria Group, Inc.(MO)

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
Latest News & Analysis
Altria Group Q2 2025 Earnings: Strategic Shifts, Dividend Sustainability & Growth of 'on!' Brand
Analyze Altria's Q2 2025 earnings, NJOY ACE exit impact, dividend sustainability, and growth in 'on!' nicotine pouches amid tobacco industry challenges.
Altria Group FDA Juul Approval Impact & Reduced-Risk Product Strategy Analysis
Altria's strategic pivot with FDA's Juul approval reshapes its reduced-risk product portfolio, intensifies competition with PMI, and influences investor outlook.
Altria Group, Inc. Market Analysis: Pricing Strategy, Legal Risks, and Dividend Sustainability
A detailed analysis of Altria's pricing strategy amid volume declines, legal challenges, and the sustainability of its ~7% dividend yield backed by strong cash flow.
Altria Group, Inc. Market Update: Dividend Resilience & Strategic Growth Amid Industry Shifts
Explore Altria's strong dividend yield, pricing power of Marlboro, growth in 'on!' nicotine pouches, and robust financial health underpinning its 2025 market position.
Altria Group Inc. (MO) Market Update: Dividend Safety Amid Strategic Smoke-Free Shift
Altria's strong free cash flow and manageable payout ratio support its dividend amid a strategic pivot to smoke-free products, despite volume declines and regulatory risks.
Altria Group, Inc. Latest Analysis: Smoke-Free Transition, Dividend Sustainability, and Market Position
Altria Group's strategic pivot to smoke-free products, UBS upgrade, and dividend outlook reveal a resilient financial position amid industry challenges.
Altria's Smoke-Free Strategy: NJOY Setbacks, 'on!' Growth & Dividend Resilience
Altria's smoke-free transition faces a stark contrast: 'on!' nicotine pouches surge while NJOY e-cigarettes hit an $873M impairment. We analyze the financial impact and dividend sustainability.
Altria Group (MO): High Dividend Yield Amidst Strategic Transformation
Altria Group ([MO](/dashboard/companies/MO)) maintains its high dividend yield amidst strategic shifts and regulatory challenges, bolstered by a recent S&P credit rating upgrade.
Altria Group (MO): Strategic Pivot, Regulatory Hurdles, and Dividend Stability
Altria Group navigates regulatory hurdles and illicit market growth while its smoke-free strategy and robust dividend yield remain central.
Altria Group's Strategic Pivot: Navigating Smoke-Free Growth
Altria Group's stock surged, reflecting investor confidence in its strategic pivot towards smoke-free products amid declining traditional cigarette volumes.
Altria (MO) Analysis: Earnings Beat, 'on!' Growth, Regulatory Risks
Altria Group navigates regulatory pressures and declining cigarette volumes with strategic focus on smoke-free products like 'on!' pouches and diversification into cannabis.
Altria Group (MO) Analysis: Dividend Stability Meets Regulatory Headwinds
An in-depth look at Altria Group's position in late May 2025, analyzing its dividend strategy, regulatory challenges, strategic pivot to reduced-risk products, and valuation.
Altria (MO) in 2025: Navigating Regulatory Risks and Market Uncertainty
Altria (MO) faces regulatory hurdles with NJOY ACE, impacting dividend sustainability. Tariffs pose limited direct threat. Stock offers safe haven during market downturns.
Altria (MO): Dividends, RRPs, and Regulatory Challenges
Analysis of Altria Group (MO): dividend appeal, reduced-risk product competition, regulatory pressures, and interest rate sensitivity shape investment decisions.
Altria (MO) Stock: Dividend Yield, Smoke-Free Transition
Altria (MO) demonstrates resilience as a safe-haven investment, balancing high dividends with smoke-free transitions amidst regulatory scrutiny and market shifts.
Altria's ($MO) Transformation: Smoke-Free Future and Dividends
Altria navigates smoke-free transition, cannabis potential, and dividend sustainability amidst illegal e-vapor challenges. A comprehensive analysis of $MO's future prospects.
Altria Group: Share Repurchase, Dividend, and Smoke-Free Strategy Analysis
Altria Group navigates a shifting market with share repurchases, dividend strategies, and smoke-free initiatives, facing regulatory and competitive challenges. Actionable insights provided.
Altria's Dividend, Smoke-Free Strategy, and Regulatory Challenges
Altria's dividend, smoke-free strategy, and regulatory challenges are under scrutiny. The company's financial strength and market dynamics are comprehensively analyzed.
Altria (MO): Navigating the Smoke-Free Future, Regulatory Hurdles, and Dividend Sustainability
Altria (MO) navigates a smoke-free future, regulatory hurdles, and dividend sustainability. Strategic shifts and market dynamics shape its path forward.
Altria's Future: Smoke-Free Products, Dividends, and Regulatory Hurdles
Altria navigates smoke-free transition, dividend sustainability, and regulatory hurdles amid shifting market dynamics and growing competition. NJOY and on! are key to the future.
Altria's Smoke-Free Revolution: Can Dividends and Innovation Coexist?
A comprehensive analysis of Altria Group's smoke-free transition, dividend strategy, and competitive market positioning.
Altria Group, Inc.: Financial Excellence | Latest Industry News
Comprehensive intraday analysis of Altria Group, Inc.'s (MO) latest developments, market trends, and strategic initiatives as of February 20, 2025.
Altria's Smoke-Free Transition and Dividend Strategy
Altria navigates smoke-free transition and dividend strategy amid regulatory shifts. Key developments, financial performance, and market impacts analyzed.